Safe and pragmatic use of sodium–glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement

Diabetes prevalence shows a continuous increasing trend in South Asia. Although well-established treatment modalities exist for type 2 diabetes mellitus (T2DM) management, they are limited by their side effect profile. Sodium–glucose co-transporter 2 inhibitors (SGLT2i) with their novel insulin-inde...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Indian J Endocrinol Metab
Huvudupphovsmän: Kalra, Sanjay, Ghosh, Sujoy, Aamir, A. H., Ahmed, Md. Tofail, Amin, Mohammod Feroz, Bajaj, Sarita, Baruah, Manash P., Bulugahapitiya, Uditha, Das, A. K., Giri, Mimi, Gunatilake, Sonali, Mahar, Saeed A., Pathan, Md. Faruque, Qureshi, Nazmul Kabir, Raza, S. Abbas, Sahay, Rakesh, Shakya, Santosh, Shreshta, Dina, Somasundaram, Noel, Sumanatilleke, Manilka, Unnikrishnan, A. G., Wijesinghe, Achini Madushani
Materialtyp: Artigo
Språk:Inglês
Publicerad: Medknow Publications & Media Pvt Ltd 2017
Ämnen:
Review Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5240067/
https://ncbi.nlm.nih.gov/pubmed/28217523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.196029
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk